5d). Similar results were also obtained from MDA-MB-231 breast cancer cells with endogenous FGFR1 expression, where c-FOS recruitment to the FOXQ1 gene promoter was increased about two folds upon bFGF treatment (Fig. Here, FGF2 is linked to breast cancer.